amyotrophic lateral sclerosis

(redirected from Charcot's disease)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Charcot's disease: Charcot foot, Charcot joint, neuropathic arthropathy, neuropathic arthritis, Charcot arthritis, Charcot arthropathy

a·my·o·tro·phic lateral sclerosis

 (ā′mī-ə-trō′fĭk, -trŏf′ĭk, ā-mī′-)
n. Abbr. ALS
A chronic, progressive disease marked by gradual degeneration of the nerve cells in the spinal cord that control voluntary muscle movement, causing muscle weakness, atrophy, and eventual paralysis. Also called Lou Gehrig's disease.

amyotrophic lateral sclerosis

(ˌæmɪəʊˈtrəʊfɪk)
n
(Pathology) a form of motor neurone disease in which degeneration of motor tracts in the spinal cord causes progressive muscular paralysis starting in the limbs. Also called: Lou Gehrig's disease

a•my•o•troph′ic lat′eral sclero′sis

(ˌeɪ maɪ əˈtrɒf ɪk, -ˈtroʊ fɪk, eɪˌmaɪ ə-)
n.
a nervous system disease in which degeneration of motor neurons in the brain stem and spinal cord leads to atrophy and paralysis of the voluntary muscles. Abbr.: ALS Also called Lou Gehrig's disease.
[1885–90; a-6 + myo- + -trophic]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.amyotrophic lateral sclerosis - thickening of tissue in the motor tracts of the lateral columns and anterior horns of the spinal cordamyotrophic lateral sclerosis - thickening of tissue in the motor tracts of the lateral columns and anterior horns of the spinal cord; results in progressive muscle atrophy that starts in the limbs
nervous disorder, neurological disease, neurological disorder - a disorder of the nervous system
induration, sclerosis - any pathological hardening or thickening of tissue
References in periodicals archive ?
About ALS (also called Motor Neuron Disease (MND), Charcot's disease or Lou Gehrig's disease)
ALS (also referred to as Motor Neuron Disease (MND), Charcot's disease or Lou Gehrig's disease) is a progressive and fatal neurological disease that affects 100,000 -120,000 people worldwide with about 1,200 new cases occurring in the UK each year.
ExonHit Therapeutics, a privately-held drug discovery company, announced it has received recommendation by an independent Data Safety Monitoring Board (DSMB) to continue its clinical trial for Ikomio, a potential treatment for Amyotrophic Lateral Sclerosis (ALS), a neurodegenerative disease commonly known as Charcot's disease or Lou Gehrig's disease.